Abstract:Background: Calcific aortic valve stenosis (CAVS) is a crucial cardiovascular disease facing aging societies. Our research attempts to identify immune-related genes through bioinformatics and machine learning analysis. Two machine learning strategies include Least Absolute Shrinkage Selection Operator (LASSO) and Support Vector Machine Recursive Feature Elimination (SVM-RFE). In addition, we deeply explore the role of immune cell infiltration in CAVS, aiming to study the potential therapeutic targets of CAVS and explore possible drugs. Methods: Download three data sets related to CAVS from the Gene Expression Omnibus. Gene set variation analysis (GSVA) looks for potential mechanisms, determines differentially expressed immune-related genes (DEIRGs) by combining the ImmPort database with CAVS differential genes, and explores the functions and pathways of enrichment. Two machine learning methods, LASSO and SVM-RFE, screen key immune signals and validate them in external data sets. Single-sample GSEA (ssGSEA) and CIBERSORT analyze the subtypes of immune infiltrating cells and integrate the analysis with DEIRGs and key immune signals. Finally, the possible targeted drugs are analyzed through the Connectivity Map (CMap). Results: GSVA analysis of the gene set suggests that it is highly correlated with multiple immune pathways. 266 differential genes (DEGs) integrate with immune genes to obtain 71 DEIRGs. Enrichment analysis found that DEIRGs are related to oxidative stress, synaptic membrane components, receptor activity, and a variety of cardiovascular diseases and immune pathways. Angiotensin II Receptor Type 1(AGTR1), Phospholipid Transfer Protein (PLTP), Secretogranin II (SCG2) are identified as key immune signals of CAVS by machine learning. Immune infiltration found that B cells naï ve and Macrophages M2 are less in CAVS, while Macrophages M0 is more in CAVS. Simultaneously, AGTR1, PLTP, SCG2 are highly correlated with a variety of immune cell subtypes. CMap analysis found that isoliquiritigenin, parthenolide, and pyrrolidine-dithiocarbamate are the top three targeted drugs related to CAVS immunity. Conclusion: The key immune signals, immune infiltration and potential drugs obtained from the research play a vital role in the pathophysiological progress of CAVS.

Calcific aortic stenosis: omics-based target discovery and therapy development

Identification of Key Genes in Calcific Aortic Valve Disease by Integrated Bioinformatics Analysis.

Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis

AGTR1, PLTP, and SCG2 Associated with Immune Genes and Immune Cell Infiltration in Calcific Aortic Valve Stenosis: Analysis from Integrated Bioinformatics and Machine Learning.

Inflammatory and metabolic mechanisms underlying the calcific aortic valve disease

The Complex Relationship between Hypoxia Signaling, Mitochondrial Dysfunction and Inflammation in Calcific Aortic Valve Disease: Insights from the Molecular Mechanisms to Therapeutic Approaches

Pathological Mechanism and Treatment of Calcified Aortic Stenosis

Integrative Multi-Omics Analysis in Calcific Aortic Valve Disease Reveals a Link to the Formation of Amyloid-Like Deposits

The burden of calcific aortic stenosis: what's behind?

Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets

Calcific aortic valve disease and cardiometabolic triggers: an explanation behind progression of aortic valvular disease and failure of medical therapy interventions

Cellular and molecular mechanisms of calcific aortic valve disease

The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease

Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation

Calcific aortic valve disease: mechanisms, prevention and treatment

Genetics of Calcific Aortic Stenosis: A Systematic Review

A Novel Mouse Model of Calcific Aortic Valve Stenosis.

Transcriptomic Analysis of Mineralized Adipose-Derived Stem Cell Tissues for Calcific Valve Disease Modelling

Research Progress on Pharmacotherapy of Calcific Aortic Valve Disease

A disease-driver population within interstitial cells of human calcific aortic valves identified via single-cell and proteomic profiling

Late-stage Calcific Aortic Valve Disease Within an Aortic Valve-on-a-chip Model